JP2018514187A5 - - Google Patents

Download PDF

Info

Publication number
JP2018514187A5
JP2018514187A5 JP2017546066A JP2017546066A JP2018514187A5 JP 2018514187 A5 JP2018514187 A5 JP 2018514187A5 JP 2017546066 A JP2017546066 A JP 2017546066A JP 2017546066 A JP2017546066 A JP 2017546066A JP 2018514187 A5 JP2018514187 A5 JP 2018514187A5
Authority
JP
Japan
Prior art keywords
risk
gene
gene set
nucleic acid
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017546066A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018514187A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/020583 external-priority patent/WO2016141127A1/en
Publication of JP2018514187A publication Critical patent/JP2018514187A/ja
Publication of JP2018514187A5 publication Critical patent/JP2018514187A5/ja
Priority to JP2022002016A priority Critical patent/JP2022050571A/ja
Withdrawn legal-status Critical Current

Links

JP2017546066A 2015-03-04 2016-03-03 発現レベルおよび配列変種情報を用いて疾患の発症または再発のリスクを評価するための方法 Withdrawn JP2018514187A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022002016A JP2022050571A (ja) 2015-03-04 2022-01-11 発現レベルおよび配列変種情報を用いて疾患の発症または再発のリスクを評価するための方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562128469P 2015-03-04 2015-03-04
US201562128463P 2015-03-04 2015-03-04
US62/128,463 2015-03-04
US62/128,469 2015-03-04
US201562238893P 2015-10-08 2015-10-08
US62/238,893 2015-10-08
PCT/US2016/020583 WO2016141127A1 (en) 2015-03-04 2016-03-03 Methods for assessing the risk of disease occurrence or recurrence using expression level and sequence variant information

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022002016A Division JP2022050571A (ja) 2015-03-04 2022-01-11 発現レベルおよび配列変種情報を用いて疾患の発症または再発のリスクを評価するための方法

Publications (2)

Publication Number Publication Date
JP2018514187A JP2018514187A (ja) 2018-06-07
JP2018514187A5 true JP2018514187A5 (enExample) 2019-04-11

Family

ID=56849098

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017546066A Withdrawn JP2018514187A (ja) 2015-03-04 2016-03-03 発現レベルおよび配列変種情報を用いて疾患の発症または再発のリスクを評価するための方法
JP2022002016A Pending JP2022050571A (ja) 2015-03-04 2022-01-11 発現レベルおよび配列変種情報を用いて疾患の発症または再発のリスクを評価するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022002016A Pending JP2022050571A (ja) 2015-03-04 2022-01-11 発現レベルおよび配列変種情報を用いて疾患の発症または再発のリスクを評価するための方法

Country Status (7)

Country Link
US (1) US20180016642A1 (enExample)
EP (1) EP3265588A4 (enExample)
JP (2) JP2018514187A (enExample)
CN (2) CN114634985A (enExample)
AU (1) AU2016226253A1 (enExample)
CA (1) CA2978442A1 (enExample)
WO (1) WO2016141127A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008058018A2 (en) 2006-11-02 2008-05-15 Mayo Foundation For Medical Education And Research Predicting cancer outcome
EP2806054A1 (en) 2008-05-28 2014-11-26 Genomedx Biosciences Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
EP2430574A1 (en) 2009-04-30 2012-03-21 Patientslikeme, Inc. Systems and methods for encouragement of data submission in online communities
JP6078339B2 (ja) 2009-05-07 2017-02-08 ベラサイト インコーポレイテッド 甲状腺状態の診断のための方法および組成物
US20250263795A1 (en) * 2009-05-07 2025-08-21 Veracyte, Inc. Methods for classification of tissue samples as positive or negative for cancer
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
WO2013090620A1 (en) 2011-12-13 2013-06-20 Genomedx Biosciences, Inc. Cancer diagnostics using non-coding transcripts
ES2945036T3 (es) 2012-08-16 2023-06-28 Veracyte Sd Inc Pronóstico del cáncer de próstata mediante biomarcadores
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
EP3770274A1 (en) 2014-11-05 2021-01-27 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
US10395759B2 (en) 2015-05-18 2019-08-27 Regeneron Pharmaceuticals, Inc. Methods and systems for copy number variant detection
CN109074426B (zh) 2016-02-12 2022-07-26 瑞泽恩制药公司 用于检测异常核型的方法和系统
US11414708B2 (en) 2016-08-24 2022-08-16 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
US20190264264A1 (en) * 2016-10-26 2019-08-29 Integrated Nano-Technologies, Inc. Systems and methods for analyzing rna transcripts
AU2018210695B2 (en) 2017-01-20 2024-07-18 The University Of British Columbia Molecular subtyping, prognosis, and treatment of bladder cancer
WO2018152093A1 (en) * 2017-02-15 2018-08-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method of diagnosing cancer using mitochondrial dna heterogeneity
US11873532B2 (en) 2017-03-09 2024-01-16 Decipher Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
WO2018205035A1 (en) 2017-05-12 2018-11-15 Genomedx Biosciences, Inc Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
WO2019023517A2 (en) * 2017-07-27 2019-01-31 Veracyte, Inc. GENOMIC SEQUENCING CLASSIFIER
US12417825B2 (en) 2017-09-15 2025-09-16 Alden Scientific, Inc. Systems and methods for collecting and analyzing comprehensive medical information
CN108416190A (zh) * 2018-02-11 2018-08-17 广州市碳码科技有限责任公司 基于深度学习的肿瘤早期筛查方法、装置、设备及介质
CN112585270B (zh) * 2018-08-15 2023-12-05 中国科学院遗传与发育生物学研究所 评估或改善脑功能、学习能力或记忆力的组合物和方法
AU2019356497B2 (en) * 2018-10-08 2025-06-26 Freenome Holdings, Inc. Transcription factor profiling
US11894139B1 (en) * 2018-12-03 2024-02-06 Patientslikeme Llc Disease spectrum classification
WO2021055517A1 (en) * 2019-09-16 2021-03-25 The Board Of Trustees Of The Leland Stanford Junior University Methods of treatments based upon molecular characterization of breast cancer
GB201914193D0 (en) * 2019-10-02 2019-11-13 Aldo Faisal Digital biomarkers of movement for diagnosis
JP7721538B2 (ja) 2020-01-09 2025-08-12 ホワイトラビット・エーアイ・インコーポレイテッド リアルタイム放射線医学を行うための方法およびシステム
JP7570088B2 (ja) * 2020-06-18 2024-10-21 国立研究開発法人産業技術総合研究所 情報処理システム、情報処理方法、同定方法及びプログラム
CN112326965B (zh) * 2020-10-22 2022-03-04 南京医科大学 Daam1蛋白在制备肾透明细胞癌诊断及预后评估试剂盒中的应用
CN114622007A (zh) * 2020-12-10 2022-06-14 深圳先进技术研究院 一种Cox6c检测引物及其应用
US11367521B1 (en) 2020-12-29 2022-06-21 Kpn Innovations, Llc. System and method for generating a mesodermal outline nourishment program
CN112715484B (zh) * 2020-12-29 2022-04-22 四川省人民医院 构建视网膜色素变性疾病模型的方法、应用以及繁育方法
CN113504370B (zh) * 2021-06-29 2024-02-09 广州金研生物医药研究院有限公司 Mapk15蛋白在前列腺癌的恶性程度或预后程度预测中的应用
US20250259750A1 (en) * 2022-04-15 2025-08-14 Memorial Sloan-Kettering Cancer Center Multi-modal machine learning to determine risk stratification
WO2024186815A1 (en) * 2023-03-06 2024-09-12 Exactech, Inc. Improved computer-based joint arthroplasty system and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2765591B1 (fr) * 1997-07-01 2002-08-09 Pasteur Institut Procede de diagnostic de la maladie d'alzheimer
EP1644858B1 (en) * 2003-07-10 2017-12-06 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
GB0417740D0 (en) * 2004-08-10 2004-09-08 Uc3 Methods and kit for the prognosis of breast cancer
US20110312520A1 (en) * 2010-05-11 2011-12-22 Veracyte, Inc. Methods and compositions for diagnosing conditions
US20130303826A1 (en) * 2011-01-11 2013-11-14 University Health Network Prognostic signature for oral squamous cell carcinoma
EP2771487A1 (en) * 2011-10-27 2014-09-03 Asuragen, INC. Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
JP2013212052A (ja) * 2012-03-30 2013-10-17 Yale Univ Krasバリアントおよび腫瘍生物学

Similar Documents

Publication Publication Date Title
JP2018514187A5 (enExample)
CN105189748B (zh) 测序免疫组库的方法
JP6392904B2 (ja) Dnaのサイズに基づく解析
ES2868328T3 (es) Cuantificación precisa y masivamente paralela de ácido nucleico
CN107077537B (zh) 用短读测序数据检测重复扩增
CA3180334A1 (en) Methods for detection of donor-derived cell-free dna
RU2766004C1 (ru) Способ оценки нормального состояния иммунного репертуара и его применение
ES2990200T3 (es) Análisis paralelo múltiplex de regiones genómicas blanco para análisis prenatales no invasivos
ES2990062T3 (es) Sistemas y métodos para determinar si un sujeto tiene una condición de cáncer utilizando aprendizaje por transferencia
US20130078633A1 (en) Detection of Isotype Profiles as Signatures for Disease
JP2018531044A6 (ja) 免疫レパートリーの正常性の評価方法およびその使用
CN106047991A (zh) 用于检测川崎病的方法及试剂盒
ES2987603T3 (es) Regulación genética de la respuesta inmunitaria por interacciones cromosómicas
ES2942546T3 (es) Métodos de alta sensibilidad para la cuantificación paralela precisa de ácidos nucleicos
KR102801954B1 (ko) 개체의 면역 레퍼토리에서의 변화를 측정하는 방법
JP6688418B1 (ja) 2型糖尿病のリスクを判定する方法
TW202449173A (zh) 長核酸片段的有效數位量測
WO2024086499A1 (en) Systems and methods for detecting fusion genes from sequencing data
JP7140707B2 (ja) 緑内障のリスクを判定する方法
Bhat et al. DNA methylation detection at single base resolution using targeted next generation bisulfite sequencing and cross validation using capillary sequencing
Hiyoshi-Kanemoto et al. Detection of circulating tumor cells using GeneScan analysis for antigen receptor gene rearrangements in canine lymphoma patients
US20250171858A1 (en) Enrichment of clinically-relevant nucleic acids
JP2020178589A (ja) リウマチのリスクを判定する方法
JP2020178561A (ja) 心筋梗塞及び/又は狭心症のリスクを判定する方法
JP2020178562A (ja) 心房細動及び/又は心室細動のリスクを判定する方法